Related Experiment Video
Updated: Feb 16, 2026

Quantitative PCR of T7 Bacteriophage from Biopanning
Published on: September 27, 2018
Detection of Cystic Fibrosis Serological Biomarkers Using a T7 Phage Display Library
Harvinder Talwar1, Samer Najeeb Hanoudi2, Andreea Geamanu1
1Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine and Detroit Medical Center, Detroit, MI, 48201, USA.
Researchers identified novel cystic fibrosis (CF) specific serological biomarkers using a T7 phage display library. These biomarkers accurately distinguish CF patients, aiding potential molecular therapy development.
Area of Science:
- Biochemistry
- Immunology
- Genetics
Background:
- Cystic fibrosis (CF) is an autosomal recessive disorder caused by CFTR gene mutations.
- CF leads to recurrent lung infections and respiratory failure.
- Current diagnostic methods can be invasive or lack specificity.
Purpose of the Study:
- To develop and validate a high-throughput method for identifying CF-specific serological biomarkers.
- To assess the diagnostic accuracy of identified biomarkers.
- To explore the utility of these biomarkers in clinical practice.
Main Methods:
- Constructed a T7 phage display cDNA library from bronchoalveolar lavage cells and leukocytes.
- Biopanned the library to identify potential antigens.
- Immunoscreened a microarray with sera from healthy, lung cancer, and CF subjects.
- Utilized naïve Bayes models and validated classifier performance.
Main Results:
- Identified 20 significant CF-specific clones with high accuracy (ROC AUC 0.973, sensitivity 0.999, specificity 0.959).
- Selected clones showed high correlation with sweat chloride test, BMI, and FEV1% predicted values.
- Demonstrated high diagnostic performance in an independent validation set.
Conclusions:
- Successfully identified CF-specific serological biomarkers using a T7 phage display library.
- These biomarkers exhibit high accuracy for CF diagnosis.
- The findings suggest potential for developing novel molecular therapies and diagnostic tools for CF.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
07:32Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019